Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more?
Publication
, Journal Article
Fanaroff, AC; Lopes, RD
Published in: Eur J Intern Med
January 2021
Duke Scholars
Published In
Eur J Intern Med
DOI
EISSN
1879-0828
Publication Date
January 2021
Volume
83
Start / End Page
8 / 9
Location
Netherlands
Related Subject Headings
- Humans
- General & Internal Medicine
- Cardiovascular Diseases
- Blood Coagulation
- Atherosclerosis
- Anticoagulants
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Fanaroff, A. C., & Lopes, R. D. (2021). Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more? Eur J Intern Med, 83, 8–9. https://doi.org/10.1016/j.ejim.2020.12.004
Fanaroff, Alexander C., and Renato D. Lopes. “Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more?” Eur J Intern Med 83 (January 2021): 8–9. https://doi.org/10.1016/j.ejim.2020.12.004.
Fanaroff AC, Lopes RD. Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more? Eur J Intern Med. 2021 Jan;83:8–9.
Fanaroff, Alexander C., and Renato D. Lopes. “Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more?” Eur J Intern Med, vol. 83, Jan. 2021, pp. 8–9. Pubmed, doi:10.1016/j.ejim.2020.12.004.
Fanaroff AC, Lopes RD. Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more? Eur J Intern Med. 2021 Jan;83:8–9.
Published In
Eur J Intern Med
DOI
EISSN
1879-0828
Publication Date
January 2021
Volume
83
Start / End Page
8 / 9
Location
Netherlands
Related Subject Headings
- Humans
- General & Internal Medicine
- Cardiovascular Diseases
- Blood Coagulation
- Atherosclerosis
- Anticoagulants
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences